EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
68 hedge funds and large institutions have $158M invested in Eiger BioPharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 24 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
28% more funds holding
Funds holding: 53 → 68 (+15)
Holders
68
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$24.5M | |
| 2 | +$11.1M | |
| 3 | +$9.95M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$6.86M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$5.65M |
Top Sellers
| 1 | -$15.2M | |
| 2 | -$4.1M | |
| 3 | -$3.63M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$927K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$600K |